{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-286850","form_type":"8-K","ticker":"SCLX","cik":"0001820190","company_name":"Scilex Holding Co","filed_at":"2023-12-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.712368+00:00","generated_at":"2026-06-07T19:30:51.814040+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Scilex reports preliminary Nov ZTlido gross sales $14-15M; YTD $125-135M (+48-60% YoY); FY2023 projected $140-150M","bullets":["ZTlido gross sales YTD Nov 2023: $125-135M vs $84.6M YTD Nov 2022, growth 48-60%.","ZTlido net sales YTD Nov 2023: $40-43M vs $33.9M YTD Nov 2022, growth 18-27%.","Total product net sales YTD Nov 2023: $41-44M vs $33.9M YTD Nov 2022, growth 21-30%.","November 2023 total product net sales estimated $4.0-4.6M.","Full-year 2023 ZTlido gross sales projected $140-150M vs $96M in 2022, growth 46-56%."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-286850","json":"https://secwatch.observer/filing/0001193125-23-286850.json","markdown":"https://secwatch.observer/filing/0001193125-23-286850.md","text":"https://secwatch.observer/filing/0001193125-23-286850.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1820190/000119312523286850/0001193125-23-286850-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1820190/000119312523286850/d939341d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T19:30:51.814040+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4e4baf54d52f9e9c0cfa279618111b2f2fdf986d","claim":"Scilex Holding Co reported One month ended November 30, 2023 and year-to-date through November 30, 2023 results: revenue ZTlido gross sales for November 2023 were in the range of $14.0 million to $15.0 million with year-to-date gross sales t.","evidence_excerpt":"Scilex Holding Company (the “Company”) is providing certain preliminary unaudited financial results for the one month ended November 30, 2023 and year-to-date through November 30, 2023, based on currently available information.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1820190/000119312523286850/0001193125-23-286850-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"One month ended November 30, 2023 and year-to-date through November 30, 2023"},{"label":"Revenue","value":"ZTlido gross sales for November 2023 were in the range of $14.0 million to $15.0 million with year-to-date gross sales t"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"},{"claim_id":"b5efdfad9064e12d32296b77ff45f9fc22cafafe","claim":"Scilex Holding Co reported Full year 2023 results: revenue Projected full year gross sales for ZTlido in 2023 are estimated to be in the range of $140.0 million to $150.0 million.","evidence_excerpt":"Projected full year gross sales for ZTlido in 2023 are estimated to be in the range of $140.0 million to $150.0 million, compared to $96.0 million in 2022, representing estimated growth in the range of approximately 46% to 56%.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1820190/000119312523286850/0001193125-23-286850-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Full year 2023"},{"label":"Revenue","value":"Projected full year gross sales for ZTlido in 2023 are estimated to be in the range of $140.0 million to $150.0 million"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}